TrumpRx, a federal purchasing portal announced November 2025 and launching January 2026, uses the threat of 100% tariffs on pharmaceutical imports to force Novo Nordisk, Eli Lilly, and other manufacturers into Most Favored Nation pricing agreements that bring GLP-1 injectables down to ~$350/month for cash-pay users, bypassing the insurance, PBM, and traditional pharmacies & competing directly with Ro by redirecting patients who search for drugs on TrumpRx.gov to the same manufacturer cash-pay pharmacies Ro pipes into
Seek FDA-approved medications: If prescribed GLP-1 agonists, ensure you receive the brand name medication from a reputable pharmacy
Again, exercise using the upper arm muscles may increase this rate of absorption
A Kaiser member in Colorado might have a completely different experience than one in Georgia
However, a direct comparison between CAF and PXN regarding their impact on cognition and associated mechanisms is lacking
Fewer Glucose Excursions The amplitude of blood sugar swings declined significantly
